These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3242843)

  • 21. Comparison of short-term treatment regimen of ciprofloxacin versus long-term treatment regimens of trimethoprim/sulfamethoxazole or norfloxacin for uncomplicated lower urinary tract infections: a randomized, multicentre, open-label, prospective study.
    Arredondo-García JL; Figueroa-Damián R; Rosas A; Jáuregui A; Corral M; Costa A; Merlos RM; Ríos-Fabra A; Amábile-Cuevas CF; Hernández-Oliva GM; Olguín J; Cardeñosa-Guerra O;
    J Antimicrob Chemother; 2004 Oct; 54(4):840-3. PubMed ID: 15347634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DUE of ciprofloxacin in the treatment of urinary tract infections in hospitalized patients.
    Dydek GJ; Souney PF; Matthews SJ
    Hosp Formul; 1992 Feb; 27(2):185-91. PubMed ID: 10116716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ciprofloxacin (BAY 09867): clinical evaluation in urinary tract infections due to Pseudomonas aeruginosa.
    Guibert JM; Destree DM; Acar JF
    Chemioterapia; 1987 Jun; 6(2 Suppl):524-5. PubMed ID: 3151352
    [No Abstract]   [Full Text] [Related]  

  • 24. [The efficacy and tolerance of Bay-o-9867 (ciprofloxacin) in the treatment of infections of the urinary tract and of the lower respiratory tract].
    Quartieri F; Bolognesi S; Sconosciuto F
    Recenti Prog Med; 1994 Feb; 85(2):96-100. PubMed ID: 8184195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral ciprofloxacin in resistant urinary tract infections.
    Ryan JL; Berenson CS; Greco TP; Mangi RJ; Sims M; Thornton GF; Andriole VT
    Am J Med; 1987 Apr; 82(4A):303-6. PubMed ID: 3555052
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of ciprofloxacin and beta-lactam antibiotics in the treatment of urinary tract infections and alteration of fecal flora.
    Daikos GL; Kathpalia SB; Sharifi R; Lolans VT; Jackson GG
    Am J Med; 1987 Apr; 82(4A):290-4. PubMed ID: 3555050
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Once-daily fleroxacin versus twice-daily ciprofloxacin in the treatment of complicated urinary tract infections.
    Frankenschmidt A; Naber KG; Bischoff W; Kullmann K
    J Urol; 1997 Oct; 158(4):1494-9. PubMed ID: 9302150
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.
    Arslan H; Azap OK; Ergönül O; Timurkaynak F;
    J Antimicrob Chemother; 2005 Nov; 56(5):914-8. PubMed ID: 16174685
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Efficacy and tolerance of a five day course of ciprofloxacin in the treatment of urinary tract infection in women. Multicenter study].
    Prado V; Haristoy J; Montaño R; Castrillón M; Sepúlveda S; Zemelman R; Flaskamp R; Martínez J; Cumsille F
    Rev Med Chil; 1998 Jan; 126(1):49-55. PubMed ID: 9629754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of urinary tract infections with ciprofloxacin after renal transplantation.
    Grekas D; Thanos V; Dioudis C; Alivanis P; Tourkantonis A
    Int J Clin Pharmacol Ther Toxicol; 1993 Jun; 31(6):309-11. PubMed ID: 8335429
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Criteria for use of intravenous ciprofloxacin for infections in adult patients.
    Frisolone J; Manzo J; Leviton IM
    Clin Pharm; 1993 Mar; 12(3):226-32. PubMed ID: 8491080
    [No Abstract]   [Full Text] [Related]  

  • 32. [Microbiological evaluation of ciprofloxacin efficacy for treatment of urinary tract infections].
    Kalisz J; Denys A; Szczerba W; Rusinek A; Rogowska-Kalisz A
    Med Dosw Mikrobiol; 1996; 48(3-4):169-75. PubMed ID: 9182138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ciprofloxacin in urinary tract infections.
    Høiby N
    Scand J Infect Dis Suppl; 1989; 60():54-7. PubMed ID: 2667108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single-dose ciprofloxacin at 100 versus 250 mg for treatment of uncomplicated urinary tract infections in women.
    Garlando F; Rietiker S; Täuber MG; Flepp M; Meier B; Lüthy R
    Antimicrob Agents Chemother; 1987 Feb; 31(2):354-6. PubMed ID: 3551837
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Oral therapy with ciprofloxacin in the prophylaxis of urinary infections in surgical patients with permanent bladder catheter].
    Salvestrini F; Oliva G; Mattei FM
    Minerva Chir; 1996; 51(7-8):625-8. PubMed ID: 8975169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ciprofloxacin in the treatment of complicated urinary tract infections.
    Naber K; Sörgel F
    Chemioterapia; 1987 Jun; 6(2 Suppl):522-3. PubMed ID: 3509488
    [No Abstract]   [Full Text] [Related]  

  • 37. [Tavanik effectiveness and safety in the treatment of urinary tract infection complications].
    Loran OB; Pushkar' DIu; Rasner PI
    Klin Med (Mosk); 2001; 79(12):35-8. PubMed ID: 11840809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biotyping and susceptibility behaviour of pathogens in patients treated with ciprofloxacin.
    Krasemann C; Von Poppel H; Wegge M; Chysky V
    J Chemother; 1989 Jul; 1(4 Suppl):386-8. PubMed ID: 16312452
    [No Abstract]   [Full Text] [Related]  

  • 39. Uncomplicate the treatment of uncomplicated urinary tract infections.
    Ditmanson LF; Apgar DA
    Arch Intern Med; 1996 Jan; 156(1):111-3. PubMed ID: 8526690
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparison of three dosage regimens of ciprofloxacin in urinary tract infections.
    Prát V; Horcicková M; Matousovic K; Hatala M
    Int Urol Nephrol; 1990; 22(3):201-7. PubMed ID: 2210972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.